Morales-Briceño, Hugo http://orcid.org/0000-0002-1104-4151
Ha, Ainhi D.
Chiang, Han-Lin
Tai, Yicheng
Chang, Florence C. F.
Tsui, David S.
Griffith, Jane
Galea, Donna
Kim, Samuel D.
Cruse, Belinda
Mahant, Neil http://orcid.org/0000-0003-0527-3932
Fung, Victor S. C. http://orcid.org/0000-0003-3085-2282
Funding for this research was provided by:
AbbVie Inc. | AbbVie Biotherapeutics
Article History
Received: 30 November 2022
Accepted: 15 May 2023
First Online: 29 June 2023
Competing interests
: The authors declare no competing non-financial interests but the following competing financial interests: Hugo Morales’s position was funded by an unrestricted donation (the Baffsky Parkinson’s Disease Research Fund) and administered by the Western Sydney Local Health District. Han-Lin Chiang and Yicheng Tai have no financial disclosures. Neil Mahant, Ainhi Ha, Florence Chang, David Tsui and Samuel Kim receive salary from NSW Health. Jane Griffith and Donna Galea nursing salaries are partly funded by unrestricted grants to the Western Sydney Local Health District from Abbvie. Victor Fung receives a salary from NSW Health, has received research grants from the National Health and Medical Research Council of Australia, and is on advisory boards and/or has received travel grants from Abbott/AbbVie, Allergan, Boehringer-Ingelheim, Hospira, Ipsen, Lundbeck, Novartis, Parkinson’s KinetiGraph, Solvay, and UCB. The remaining authors declare no competing interests.